Most trials concern postmenopausal patients having axillary node metastasis, but results from the Scottish trial showed a highly significant delay in relapse in the tamoxifen treated patients compared to the control arm patients, irrespective of menopausal or nodal status (Anonymous, 1987).
2
—
—
The sentences
Total-C showed a trend to decrease, especially in the premenopausal women.